全、新、優(yōu)、品、好四大特點(diǎn)：

受體相關(guān)因子6抗體說(shuō)明書(shū) 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。

受體相關(guān)因子6抗體說(shuō)明書(shū) 英文名稱  Anti-TRAF6

中文名稱  受體相關(guān)因子6抗體說(shuō)明書(shū) 

別    名 TNF receptor-associated factor 6; Interleukin 1 signal transducer; MGC 3310; MGC3310; RING finger protein 85; RNF 85; RNF85; TRAF 6; TRAF6_HUMAN.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來(lái)源  Rabbit

克隆類(lèi)型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat

產(chǎn)品類(lèi)型   一抗  

研究領(lǐng)域     信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 細(xì)胞膜受體

蛋白分子量  predicted molecular weight: 60kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human TRAF6

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

受體相關(guān)因子6抗體說(shuō)明書(shū) 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from members of the TNF receptor superfamily. This protein mediates the signaling not only from the members of the TNF receptor superfamily, but also from the members of the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. Two alternatively spliced transcript variants encoding identical proteins have been reported. [provided by RefSeq].

Function : E3 ubiquitin ligase that, together with UBE2N and UBE2V1, mediates the synthesis of 'Lys-63'-linked-polyubiquitin chains conjugated to proteins, such as IKBKG, AKT1 and AKT2. Also mediates ubiquitination of free/unanchored polyubiquitin chain that leads to MAP3K7 activation. Leads to the activation of NF-kappa-B and JUN. May be essential for the formation of functional osteoclasts. Seems to also play a role in dendritic cells (DCs) maturation and/or activation. Represses c-Myb-mediated transactivation, in B-lymphocytes. Adapter protein that seems to play a role in signal transduction initiated via TNF receptor, IL-1 receptor and IL-17 receptor. Regulates osteoclast differentiation by mediating the activation of adapter protein complex 1 (AP-1) and NF-kappa-B, in response to RANK-L stimulation.

Subunit : Homotrimer. Homooligomer. N-terminal region is dimeric while C-terminal region is trimeric; maybe providing a mode of oligomerization. Upon IL1B treatment, forms a complex with PELI1, IRAK1, IRAK4 and MYD88; this complex recruits MAP3K7/TAK1, TAB1 and TAB2 to mediate NF-kappa-B activation. Direct binding of SMAD6 to PELI1 prevents the complex formation and hence negatively regulates IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression. Binds to TNFRSF5/CD40 and TNFRSF11A/RANK. Associates with NGFR, TNFRSF17, IRAK2, IRAK3, RIPK2, MAP3K1, MAP3K5, MAP3K14, CSK, TRAF, TRAF-interacting protein TRIP and TNF receptor associated protein TDP2. Interacts with IL17R. Interacts with SQSTM1 bridging NTRK1 and NGFR. Forms a ternary complex with SQSTM1 and PRKCZ (By similarity). Interacts with PELI2 and PELI3. Binds UBE2V1. Interacts with MAVS/IPS1. Interacts with TAX1BP1. Interacts with IL1RL1. Interacts with TRAFD1. Interacts with ZNF675. Interacts with AJUBA. Interacts with TICAM1 and TICAM2. Interacts with ZFAND5. Interacts with ARRB1 and ARRB2. Interacts with MAP3K7 and TAB1/MAP3K7IP1; during IL-1 signaling. Interacts with UBE2N. Interacts with TGFBR1, HDAC1 and RANGAP1. Interacts with AKT1, AKT2 and AKT3. Interacts (via TRAF domains) with NUMBL (via C-terminal). Interacts (via TRAF domains) with WDR34 (via WD domains). Interacts with RBCK1. Interacts with TRAF3IP2. Interacts with LIMD1 (via LIM domains) (By similarity). Interacts with RSAD2/viperin (By similarity). Interacts with IFIT3 (via N-terminus). Interacts (via C-terminus) with EIF2AK2/PKR (via the kinase catalytic domain) (By similarity).

Subcellular Location : Cytoplasm. Cytoplasm, cell cortex. Nucleus. Lipid droplet (By similarity). Note=Found in the nuclei of some agressive B-cell lymphoma cell lines as well as in the nuclei of both resting and activated T- and B-lymphocytes. Found in punctate nuclear body protein complexes. Ubiquitination may occur in the cytoplasm and sumoylation in the nucleus. RSAD2/viperin recruits it to the lipid droplet (By similarity).

Tissue Specificity : Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.

Post-translational modifications : Sumoylated on Lys-124, Lys-142 and Lys-453 with SUMO1.

Polyubiquitinated on Lys-124; after cell stimulation with IL-1-beta or TGF-beta. This ligand-induced cell stimulation leads to dimerization/oligomerization of TRAF6 molecules, followed by auto-ubiquitination which involves UBE2N and UBE2V1 and leads to TRAF6 activation. This 'Lys-63' site-specific poly-ubiquitination appears to be associated with the activation of signaling molecules. Endogenous autoubiquitination occurs only for the cytoplasmic form.

Similarity : Belongs to the TNF receptor-associated factor family. A subfamily.

Contains 1 MATH domain.

Contains 1 RING-type zinc finger.

Contains 2 TRAF-type zinc fingers.

Database links : UniProtKB/Swiss-Prot: Q9Y4K3.1

TRAF6是TRAF家族中*的成員，是NF-kappaB通路的一種信號(hào)轉(zhuǎn)導(dǎo)子，TRAF6分布較廣泛，在腦、肺、肝、骨骼肌及*分布較高，在、*和睪丸也有表達(dá)。

實(shí)驗(yàn)流程：

正在熱銷(xiāo)的相關(guān)產(chǎn)品：

Anti-P2Y4 receptor/P2ry4 /FITC 熒光素標(biāo)記P2Y4受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti-Mink IgG/HRP 辣根過(guò)氧化物酶標(biāo)兔抗水貂抗體IgGMulti-class antibodies規(guī)格： 0.1ml

細(xì)胞角蛋白4抗體 Anti-CK4 0.1ml

Mouse Anti-Rabbit IgM/RBITC 羅丹明標(biāo)記的小鼠抗兔IgM 0.1ml

Phospho-FLT3(Tyr591) 英文名稱： 磷酸化FMS樣酪酸激酶3 0.1ml

Rhesus antibody Rh PITX3 因子3抗體(穿透素) 規(guī)格 0.2ml

Rabbit Anti-Mink IgG/HRP 辣根過(guò)氧化物酶標(biāo)兔抗水貂抗體IgGMulti-class antibodies規(guī)格： 0.1ml

MDR1(multidrug resistance 1) 多藥耐藥蛋白抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-beta-Amyloid 1-42(CT) β淀粉樣肽1-42 (C端)抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh Phospho-BMX/ETK (Tyr556) 磷酸化非受體性蛋白酪氨酸激酶ETK抗體 規(guī)格 0.1ml

TBS緩沖液 100ml 0.05mol/L pH 7.6

Vitronectin 英文名稱： 玻璃粘連蛋白抗體 0.1ml

phospho-DAB2 (Ser24) 英文名稱： 磷酸化信號(hào)轉(zhuǎn)導(dǎo)功能磷蛋白DAB2抗體 0.1ml

Anti-beta-Amyloid 1-42(CT) β淀粉樣肽1-42 (C端)抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-AFP/HRP 辣根過(guò)氧化物酶標(biāo)記鼠抗人甲胎蛋白單克隆抗體(檢測(cè))IgGMulti-class antibodies規(guī)格： 0.2ml

Nadrin peptide 發(fā)育調(diào)節(jié)蛋白多肽抗原Multi-class antibodies規(guī)格： 0.5mg

APP淀粉樣肽前體蛋白抗體 Anti-APP/Amyloid beta A4 0.1ml

phospho-ZCWCC1 (Ser739) 英文名稱： 磷酸化ZCWCC1抗體 0.1ml

DSPP 英文名稱： 牙本質(zhì)磷蛋白抗體 0.1ml

Rhesus antibody Rh Phospho-eNOS(Thr495) 磷酸化合成酶3抗體(內(nèi)皮型) 規(guī)格 0.1ml

Nadrin peptide 發(fā)育調(diào)節(jié)蛋白多肽抗原Multi-class antibodies規(guī)格： 0.5mg

人β-促脂素(β-LPH)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝

兔子端粒酶(TE)免疫試劑盒 Rabbit telomerase,TE ELISA Kit

軟骨寡聚蛋白(COMP)ELISA試劑盒 ，英文名： COMP ELISA Kit

Porcineplasminogenactivatorinhibitor1,PAI-1ELISA試劑盒豬纖溶酶原激活物抑制因子1(PAI-1)ELISA試劑盒規(guī)格：96T/48T

HumanAngiopoietin4,ANG-4ELISA試劑盒人生成素4(ANG-4)ELISA試劑盒規(guī)格：96T/48T

HumanAtaxiatelangiectasiamated,ATMELISAKit人性突變基因(ATM)ELISA試劑盒規(guī)格：96T/48T

大鼠視黃醇結(jié)合蛋白4(RBP-4)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝

人糖原磷酸化酶同工酶MM(GP-MM)免疫試劑盒 Human Glycogen phosphorylase MM,GP-MM ELISA Kit

NADPH-細(xì)胞色素C還原酶(NCR)測(cè)試盒 可見(jiàn)分光光度法 50管/48樣

RatsubstancePreceptor,SP-RELISA試劑盒大鼠P物質(zhì)受體(SP-R)ELISA試劑盒規(guī)格：96T/48T

HumanLactateDehydrogenase,LDHELISA試劑盒人乳酸脫氫酶(LDH)ELISA試劑盒規(guī)格：96T/48T

HumanNeurokininsB，NKBELISAKit人神經(jīng)激肽B(NKB)ELISA試劑盒規(guī)格：96T/48T

受體相關(guān)因子6抗體說(shuō)明書(shū) 大鼠脫氧酚/脫氧啉(DPD)ELISA試劑盒 ，英文名： DPD ELISA Kit

人游離特異性抗原(fPSA)ELISA檢測(cè)試劑盒HumanFreeProstateSpecificAigen,fPSAELISAKit 96T/48T

倉(cāng)鼠基質(zhì)金屬蛋白酶9/明膠酶B(MMP-9/Gelatinase B) 免疫試劑盒 Hamster maix metalloproteinase 9/Gelatinase B,MMP-9 ELISA Kit

CLIAKitforPY(Humanpyridiniumcrosslink/PyriLinks)ELISAKit人交聯(lián)物規(guī)格：48T/96T

石蠟切片脂質(zhì)過(guò)氧化物反式十八碳四烯酸(cis-parinaricacid)熒光染色試劑盒10次

ELISAKitBMP-4人骨成型蛋白4規(guī)格：48T/96T

技術(shù)外包服務(wù):

★受體相關(guān)因子6抗體說(shuō)明書(shū) 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。